RedHill Biopharma (RDHL) Liabilities and Shareholders Equity (2022 - 2024)
RedHill Biopharma (RDHL) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $18.0 million as the latest value for Q4 2024.
RedHill Biopharma (RDHL) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $18.0 million as the latest value for Q4 2024.